Benzinga · Feb 2, 2026
AL
NASDAQ · ALPS
Alps Group Inc
Healthcare · Biotechnology
$0.40
Up+$0.00 (+0.03%)
Updated Sep 20, 2026, 1:43 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 159.74M
- P/E ratio
- -1.24
- Dividend yield
- 0.00%
- 52-week range
- $0.23 – $1.39
- Volume
- 42.94K
- Avg. volume
- 57.92K
Price performance
ALPS price history
1M range · 19 trading sessions · Daily adjusted prices
ALPS closed at $0.40 after 19 trading sessions, up 26.98% for the selected period.
- Last close
- $0.40
- Period change
- +26.98%
- Period low
- $0.31
- Period high
- $0.42
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $0.3898 | $0.40 | $0.351 | $0.40 | 42.94K |
| Sep 17, 2026 | $0.3926 | $0.40 | $0.385 | $0.3999 | 18.02K |
| Sep 16, 2026 | $0.394 | $0.40 | $0.3706 | $0.40 | 113.84K |
| Sep 15, 2026 | $0.3999 | $0.40 | $0.3993 | $0.40 | 108.78K |
| Sep 14, 2026 | $0.3996 | $0.40 | $0.391 | $0.40 | 61.13K |
| Sep 11, 2026 | $0.385 | $0.40 | $0.3849 | $0.40 | 139.82K |
| Sep 10, 2026 | $0.3802 | $0.385 | $0.38 | $0.3849 | 3.67K |
| Sep 9, 2026 | $0.381 | $0.385 | $0.3771 | $0.385 | 52.98K |
| Sep 8, 2026 | $0.38 | $0.385 | $0.377 | $0.385 | 51.61K |
| Sep 4, 2026 | $0.371 | $0.38 | $0.37 | $0.38 | 48.64K |
| Sep 3, 2026 | $0.3938 | $0.3938 | $0.375 | $0.38 | 63.97K |
| Sep 2, 2026 | $0.381 | $0.381 | $0.37 | $0.38 | 66.84K |
| Sep 1, 2026 | $0.38 | $0.3896 | $0.3768 | $0.3895 | 41.18K |
| Aug 31, 2026 | $0.3748 | $0.39 | $0.3705 | $0.3899 | 36.79K |
| Aug 28, 2026 | $0.40 | $0.4109 | $0.37 | $0.3849 | 61.71K |
| Aug 27, 2026 | $0.408 | $0.4193 | $0.3736 | $0.41 | 114.18K |
| Aug 26, 2026 | $0.2995 | $0.42 | $0.2995 | $0.4199 | 316.46K |
| Aug 25, 2026 | $0.3115 | $0.3195 | $0.31 | $0.3148 | 17.93K |
| Aug 24, 2026 | $0.33 | $0.3303 | $0.299 | $0.315 | 99.8K |
Latest ALPS news
The latest Smart Investors Daily articles mentioning ALPS.
Stock researchCompany · Overview
ALPS research
Overview
Company profile and research snapshot.
Company profile
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
globenewswire.com · Oct 31, 2025
Alps Announces Closing of Business Combination with Globalink Investment Inc.
Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025 Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
